Bay Street News

Vericel to Report Second-Quarter 2020 Financial Results on August 5, 2020

CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2020 financial results and business highlights.
To participate in the live call by telephone, please call (877) 312-5881 and reference Vericel Corporation second-quarter 2020 earnings call.  If calling from outside the U.S., please use the international phone number (253) 237-1173.If you are unable to participate in the live call, the webcast will be available at http://investors.vcel.com/events-presentations until August 5, 2021.  A replay of the call will also be available until 11:00am (EDT) on August 12, 2020 by calling (855) 859-2056, or from outside the U.S. (404) 537-3406.  The conference ID is 5851304.About Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets.  The company markets two cell therapy products in the United States.  MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults.  Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area.  The company also holds an exclusive license for North American commercial rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.  For more information, please visit the company’s website at www.vcel.com.Epicel® and MACI® are registered trademarks of Vericel Corporation.  NexoBrid® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation.  © 2020 Vericel Corporation.  All rights reserved.Investor Contact:
Lee Stern
Solebury Trout
lstern@troutgroup.com
+1 646-378-2922


Bay Street News